Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exchange Capital Management Inc. reduced its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 37,739 shares of the biopharmaceutical company’s stock after selling 517 shares during the quarter. Exchange […]
Robeco Institutional Asset Management B.V. trimmed its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.6% in the 2nd quarter, Holdings Channel reports. The firm owned 3,950,525 shares of the biopharmaceutical company’s stock after selling 191,681 shares during the period. Bristol-Myers Squibb accounts for approximately 0.7% of Robeco Institutional Asset Management B.V.’s […]
Osher Van de Voorde Investment Management decreased its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 221,338 shares of the biopharmaceutical company’s stock after selling 585 shares during the period. Bristol-Myers Squibb comprises approximately 3.6% of Osher […]
DekaBank Deutsche Girozentrale lifted its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,058,391 shares of the biopharmaceutical company’s stock after purchasing an additional 40,886 shares during the period. DekaBank Deutsche Girozentrale owned 0.19% of […]
O ROURKE & COMPANY Inc lessened its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 12.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,211 shares of the biopharmaceutical company’s stock after selling 1,038 shares during the period. O ROURKE […]